DOCSLIB.ORG

Annex V, Last Update: 02/08/2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annex V, Last Update: 02/08/2021 File creation date: 26/09/2021 Annex V, Last update: 02/08/2021 LIST OF PRESERVATIVES ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Name of Common Ingredients Product Type, body concentration Update date number Chemical name / INN CAS Number EC Number Other use and Glossary parts in ready for use warnings preparation 1 Benzoic acid and its sodium salt BENZOIC ACID; SODIUM 65-85-0 / 532-32-1 200-618-2 / a) Rinse-off products, a) 2.5% (acid) 25/10/2010 BENZOATE 208-534-8 except oral care b) 1.7% (acid) products c) 0.5% (acid) b) Oral care products c) Leave-on products 1a Salts of benzoic acid other than AMMONIUM BENZOATE / 1863-63-4 /2090-05-3 / 582-25-2 217-468-9 / 0.5% (acid) 16/10/2010 that listed under reference BUTYL BENZOATE / / 553-70-8 / 4337-66-0 / 93-58-3 218-235-4 / number 1 and esters of benzoic CALCIUM BENZOATE / / 93-89-0 / 2315-68-6 / 136-60-7 209-481-3 / acid ETHYL BENZOATE / / 1205-50-3 / 939-48-0 / 93-99-2 209-045-2 / ISOBUTYL BENZOATE / 224-387-2 / ISOPROPYL BENZOATE / 202-259-7 / MAGNESIUM BENZOATE / 202-284-3 / MEA-BENZOATE / METHYL 219-020-8 / BENZOATE / PHENYL 205-252-7 / BENZOATE / POTASSIUM 204-401-3 / BENZOATE / PROPYL 213-361-6 / BENZOATE 202-293-2 2 Propionic acid and its salts PROPIONIC ACID / 79-09-4 / 17496-08-1 / 201-176-3 / 2% (acid) 16/10/2010 AMMONIUM PROPIONATE / 4075-81-4 / 557-27-7 / 327-62-8 241-503-7 / CALCIUM PROPIONATE / / 137-40-6 223-795-8 / MAGNESIUM PROPIONATE / 209-166-0 / POTASSIUM PROPIONATE / 206-323-5 / SODIUM PROPIONATE 205-290-4 3 Salicylic acid and its salts SALICYLIC ACID, CALCIUM 69-72-7[1]/ 824-35-1[2]/ 200-712-3[1]/ Salicylic acid: Salicylic acid: Salicylic acid: 27/07/2020 SALICYLATE, MAGNESIUM 18917-89-0[3]/ 59866-70-5[4]/ 212-525-4[2]/ 0,5 % (acid) Not to be used SALICYLATE, MEA- 54-21-7[5]/ 578-36-9[6]/ 242-669-3[3]/ Not to be used for children SALICYLATE, SODIUM 2174-16-5[7] 261-963-2[4]/ Salicylic acid in products for under 3 years of SALICYLATE, POTASSIUM 200-198-0[5]/ salts: 0,5 % children under 3 age** SALICYLATE, TEA- 209-421-6[6]/ (acid) years of age. **Solely for SALICYLATE 218-531-3[7] Not to be used products which in oral products. might be used Not to be used for children in applications under 3 years of that may lead to age. exposure of the end-user’s lungs Salicylic acid by inhalation. salts: Not to be used for children Salicylic acid under 3 years of Page 1/9 Substance identification Conditions Wording of Reference Maximum conditions of Name of Common Ingredients Product Type, body concentration Update date number Chemical name / INN CAS Number EC Number Other use and Glossary parts in ready for use warnings preparation salts: age*** ***Solely for Not to be used products which in products for might be used children under 3 for children years of age, under 3 years of except for age and which shampoos. remain in prolonged contact with the skin. 4 Hexa-2,4-dienoic acid and its SORBIC ACID / CALCIUM 110-44-1 / 7492-55-9 / 203-768-7 / 0.6% (acid) 16/10/2010 salts SORBATE / SODIUM 7757-81-5 / 24634-61-5 231-321-6 / SORBATE / POTASSIUM 231-819-3 / SORBATE 246-376-1 7 Biphenyl-2-ol O-PHENYLPHENOL 90-43-7 201-993-5 The use of 28/07/2020 o-phenylphenol as a preservative should be allowed with a maximum concentration of 0,15 % (as phenol) in leave-on and 0,2 % (as phenol) in rinse-off cosmetic products. Contact with eyes should be avoided. The use of sodium o-phenylphenate , potassium o-phenylphenate and MEA o-phenylphenate as preservatives should not be allowed. 9 Inorganic sulphites and SODIUM SULFITE / 7757-83-7 / 10192-30-0 / 231-821-4 / 0.2% (as free 16/10/2010 hydrogensulphites (5) AMMONIUM BISULFITE / 10196-04-0 / 10117-38-1 / 233-469-7 / SO2) AMMONIUM SULFITE / 7773-03-7 / 7631-90-5 / 233-484-9 / POTASSIUM SULFITE / 7681-57-4 / 16731-55-8 233-321-1 / Page 2/9 Substance identification Conditions Wording of Reference Maximum conditions of Name of Common Ingredients Product Type, body concentration Update date number Chemical name / INN CAS Number EC Number Other use and Glossary parts in ready for use warnings preparation POTASSIUM HYDROGEN 231-870-1 SULFITE / SODIUM /231-548-0 / BISULFITE / SODIUM 231-673-0 / METABISULFITE / 240-795-3 POTASSIUM METABISULFITE 11 Chlorobutanol CHLOROBUTANOL 57-15-8 200-317-6 0.5% Not to be used Contains 16/10/2010 in aerosol Chlorobutanol dispensers (sprays) 12 4-Hydroxybenzoic acid and its 4-HYDROXYBENZOIC ACID / 99-96-7 /99-76-3 /36457-19-9 202-804-9 0,4% (as acid) 11/08/2020 Methyl- and Ethyl-esters, and METHYLPARABEN /16782-08-4 /5026-62-0 /202-785-7 for single ester their salts /POTASSIUM /35285-68-8 /120-47-8 /114-63-6 /253-048-1 0,8% (as acid) ETHYLPARABEN /26112-0-2 /69959-44-0 /240-830-2 for mixtures of /POTASSIUM PARABEN /225-714-1 esters /SODIUM METHYLPARABEN /252-487-6 /SODIUM ETHYLPARABEN /204-399-4 /ETHYLPARABEN /SODIUM /204-051-1 PARABEN / POTASSIUM /247-464-2 METHYLPARABEN / /274-235-4 CALCIUM PARABEN 12 a Butyl 4-hydroxy-benzoate and its BUTYLPARABEN/PROPYLPA 94-26-8/ 94-13-3/ 35285-69-9/ 202-318-7/ - 0,14% (as Not to be used For leave-on 02/08/2021 salts Propyl 4-hydroxy-benzoate RABEN/SODIUM 36457-20-2/ 38566-94-8/ 202-307-7/ acid) for the sum in leave-on products and its salts PROPOYLPARABEN/SODIUM 84930-16-5 252-488-1/ of the individual products designed for BUTYLPARABEN/POTASSIU 253-049-7/ concentrations designed for children under M 254-009-1/ application on three years of BUTYLPARABEN/POTASSIU 284-597-5 - 0,8% (as acid) the nappy area age: "Do not use M PROPYLPARABEN for mixtures of of children on the nappy substances under three area" mentioned in years of age. entry 12 and 12a, here the sum of the individual concentrations of butyl and propylparaben and their salts does not exceed 0,14% 13 3-Acetyl-6-methylpyran-2,4(3H)- DEHYDROACETIC ACID / 520-45-6 / 4418-26-2 / 208-293-9 / 0.6% (as acid) Not to be used 16/10/2010 dione and its salts SODIUM 16807-48-0 224-580-1 / - in aerosol DEHYDROACETATE dispensers (sprays) 14 Formic acid and its sodium salt FORMIC ACID / SODIUM 64-18-6 / 141-53-7 200-579-1 / 0.5% (as acid) 16/10/2010 Page 3/9 Substance identification Conditions Wording of Reference Maximum conditions of Name of Common Ingredients Product Type, body concentration Update date number Chemical name / INN CAS Number EC Number Other use and Glossary parts in ready for use warnings preparation FORMATE 205-488-0 15 3,3'-Dibromo-4,4'-hexamethylene DIBROMOHEXAMIDINE 93856-83-8 299-116-4 0.1% 16/10/2010 dioxydibenzamidine and its salts ISETHIONATE (including isethionate) 16 Thiomersal THIMEROSAL 54-64-8 200-210-4 Eye products 0.007% (of Hg) Contains 16/10/2010 If mixed with Thiomersal other mercurial compounds authorized by this Regulation, the maximum concentration of Hg remains fixed at 0.007% 17 Phenylmercuric salts (including PHENYL MERCURIC 62-38-4 / 94-43-9 200-532-5 / Eye products 0.007% (of Hg) Contains 16/10/2010 borate) ACETATE / PHENYL 202-331-8 If mixed with Phenylmercuric MERCURIC BENZOATE other mercurial compounds compounds authorized by this Directive, the maximum concentration of Hg remains fixed at 0.007% 18 Undec-10-enoic acid and its salts UNDECYLENIC ACID / 112-38-9 / 6159-41-7 / 203-965-8 / - / 0.2% (as acid) 16/10/2010 POTASSIUM 3398-33-2 / 1322-14-1 / 222-264-8 / UNDECYLENATE / SODIUM 84471-25-0 / 56532-40-2 215-331-8 / UNDECYLENATE / CALCIUM 282-908-9 / UNDECYLENATE / 260-247-7 MEA-UNDECYLENATE / TEA-UNDECYLENATE 19 5-Pyrimidinamine, HEXETIDINE 141-94-6 205-513-5 0.1% 16/10/2010 1,3-bis(2-ethylhexyl)hexahydro-5 -methyl- 20 5-Bromo-5-nitro-1,3-dioxane 5-BROMO-5-NITRO-1,3-DIOX 30007-47-7 250-001-7 Rinse-off products 0.1% Avoid formation 02/08/2021 ANE of nitrosamines 21 Bronopol 2-BROMO-2-NITROPROPANE 52-51-7 200-143-0 0.1% Avoid formation 02/08/2021 -1,3-DIOL of nitrosamines 22 2,4-Dichlorobenzyl alcohol DICHLOROBENZYL 1777-82-8 217-210-5 0.15% 16/10/2010 ALCOHOL 23 1-(4-Chlorophenyl)-3-(3,4-dichlo TRICLOCARBAN 101-20-2 202-924-1 0.2% Purity criteria: 25/10/2010 rophenyl)urea (6) 3, 3', 4, 4'-Tetrachloroaz Page 4/9 Substance identification Conditions Wording of Reference Maximum conditions of Name of Common Ingredients Product Type, body concentration Update date number Chemical name / INN CAS Number EC Number Other use and Glossary parts in ready for use warnings preparation obenzene<1ppm ; 3, 3', 4, 4'-Tetrachloroaz oxybenzene<1p pm 24 Chlorocresol P-CHLORO-M-CRESOL 59-50-7 200-431-6 Not to be used in 0.2% 25/10/2010 products applied on mucous membranes 25 5-Chloro-2-(2,4-dichlorophenoxy TRICLOSAN 3380-34-5 222-182-2 (a) Toothpastes Hand (a) 0.3% 11/08/2020 )phenol soaps Body soaps/ Shower gels Deodorants (b) 0.2% (non-spray) Face powders and blemish concealers Nail products for cleaning the fingernails and toenails before the application of artificial nail systems.
Load more

Recommended publications
  • Water Quality Testing Summary
    WATER QUALITY TESTING SUMMARY A DETAILED REVIEW OF THE TEST RESULTS FOR THE DRINKING WATER PRODUCED BY THE CARY/APEX WATER TREATMENT FACILITY 2020 JOHN CONLEY (Senior Laboratory Analyst) has been employed by the Town of Cary at the Cary/Apex Water Treatment Facility Laboratory since September 2001. CARY/APEX WATER TREATMENT FACILITY 2020 WATER QUALITY TESTING SUMMARY We are pleased to present to you the Cary/ If you have any questions or concerns regarding this Apex Water Treatment Facility Test Result report, please contact Rachel Monschein, Water System Summary for 2020. This report is a snapshot of last Laboratory Supervisor, at (919) 362-5507. year’s water quality. The values contained in this report In order to ensure that tap water is safe to drink, EPA are based on single measurements or yearly averages depending on the contaminant. The Environmental prescribes regulations that limit the amount of certain Protection Agency and/or the State requires us to contaminants in water provided by public water systems. monitor for certain substances less than once per year Drinking water, including bottled water, may reasonably because the concentrations of these substances are not be expected to contain at least small amounts of some expected to vary significantly from year to year. Some of contaminants. The presence of contaminants does not the data, though representative of the water quality, is necessarily indicate the water poses a health risk. To obtain more than one year old. In these cases, the most recent more information about contaminants and potential data is included, along with the year in which the sample health effects, call the EPA’s Safe Drinking Water Hotline was taken.
    [Show full text]
  • Antiseptics and Disinfectants for the Treatment Of
    Verstraelen et al. BMC Infectious Diseases 2012, 12:148 http://www.biomedcentral.com/1471-2334/12/148 RESEARCH ARTICLE Open Access Antiseptics and disinfectants for the treatment of bacterial vaginosis: A systematic review Hans Verstraelen1*, Rita Verhelst2, Kristien Roelens1 and Marleen Temmerman1,2 Abstract Background: The study objective was to assess the available data on efficacy and tolerability of antiseptics and disinfectants in treating bacterial vaginosis (BV). Methods: A systematic search was conducted by consulting PubMed (1966-2010), CINAHL (1982-2010), IPA (1970- 2010), and the Cochrane CENTRAL databases. Clinical trials were searched for by the generic names of all antiseptics and disinfectants listed in the Anatomical Therapeutic Chemical (ATC) Classification System under the code D08A. Clinical trials were considered eligible if the efficacy of antiseptics and disinfectants in the treatment of BV was assessed in comparison to placebo or standard antibiotic treatment with metronidazole or clindamycin and if diagnosis of BV relied on standard criteria such as Amsel’s and Nugent’s criteria. Results: A total of 262 articles were found, of which 15 reports on clinical trials were assessed. Of these, four randomised controlled trials (RCTs) were withheld from analysis. Reasons for exclusion were primarily the lack of standard criteria to diagnose BV or to assess cure, and control treatment not involving placebo or standard antibiotic treatment. Risk of bias for the included studies was assessed with the Cochrane Collaboration’s tool for assessing risk of bias. Three studies showed non-inferiority of chlorhexidine and polyhexamethylene biguanide compared to metronidazole or clindamycin. One RCT found that a single vaginal douche with hydrogen peroxide was slightly, though significantly less effective than a single oral dose of metronidazole.
    [Show full text]
  • Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies
    Molecules 2010, 15, 7985-8005; doi:10.3390/molecules15117985 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Monocyclic Phenolic Acids; Hydroxy- and Polyhydroxybenzoic Acids: Occurrence and Recent Bioactivity Studies Shahriar Khadem * and Robin J. Marles Natural Health Products Directorate, Health Products and Food Branch, Health Canada, 2936 Baseline Road, Ottawa, Ontario K1A 0K9, Canada * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-613-954-7526; Fax: +1-613-954-1617. Received: 19 October 2010; in revised form: 3 November 2010 / Accepted: 4 November 2010 / Published: 8 November 2010 Abstract: Among the wide diversity of naturally occurring phenolic acids, at least 30 hydroxy- and polyhydroxybenzoic acids have been reported in the last 10 years to have biological activities. The chemical structures, natural occurrence throughout the plant, algal, bacterial, fungal and animal kingdoms, and recently described bioactivities of these phenolic and polyphenolic acids are reviewed to illustrate their wide distribution, biological and ecological importance, and potential as new leads for the development of pharmaceutical and agricultural products to improve human health and nutrition. Keywords: polyphenols; phenolic acids; hydroxybenzoic acids; natural occurrence; bioactivities 1. Introduction Phenolic compounds exist in most plant tissues as secondary metabolites, i.e. they are not essential for growth, development or reproduction but may play roles as antioxidants and in interactions between the plant and its biological environment. Phenolics are also important components of the human diet due to their potential antioxidant activity [1], their capacity to diminish oxidative stress- induced tissue damage resulted from chronic diseases [2], and their potentially important properties such as anticancer activities [3-5].
    [Show full text]
  • Parabens Preservatives for Focused Protection
    PARABENS Preservatives For Focused Protection Parabens are the most commonly used preservatives in personal care products. Parabens display a low irritation potential, have low toxicity levels, and are active against a wide spectrum of fungi and bacteria at low concentrations. They are stable and effective over a wide pH range, can withstand temperatures up to 100°C, and are biodegradable. Also, they are highly compatible with other compounds. When combining two or more Parabens, their antimicrobial performance is enhanced due to a synergistic effect. While this is not a complete listing of Paraben features, it is clear why they are such an effective preservative and so commonly used. MINIMUM INHIBITION CONCENTRATIONS (MIC) FOR PARABENS Microorganism Methyl Ethyl Propyl Butyl Aspergillus niger 600 300 300 200 Candida albicans 900 500 200 100 Pseudomonas aeruginosa 1600 1500 >900 - Bacillus cereus 1600 800 300 100 Burkholderia cepacia 600 350 200 200 Escherichia coli 1400 700 350 140 INCI CAS Staphylococcus epidermidis 2000 900 350 150 Methylparaben 99-76-3 Staphylococcus aureus 2000 1000 300 110 Ethylparaben 120-47-8 Propylparaben 94-13-3 All the Parabens have low aqueous solubility, but will dissolve in most systems Butylparaben 94-26-6 at temperatures above 60°C. When considering the solubility of Parabens, we recommend dissolving short-chained Parabens (such as Methylparaben) Appearance in the aqueous phase and longer-chained Parabens in the oil phase. If all the White, dry powder Parabens must be introduced to the water phase, pre-heating of the water is recommended. In the event that heating is undesirable, we recommend using Solubility Paraben sodium salts.
    [Show full text]
  • 01 Excipients Prelims 1..9
    Ethylparaben 1 Nonproprietary Names BP: Ethyl Hydroxybenzoate SEM 1: Excipient: ethylparaben; magnification: 600Â. JP: Ethyl Parahydroxybenzoate PhEur: Ethyl Parahydroxybenzoate E USP-NF: Ethylparaben 2 Synonyms Aethylum hydrobenzoicum; CoSept E; E214; ethylis parahydroxy- benzoas; ethyl p-hydroxybenzoate; Ethyl parasept; 4-hydroxyben- zoic acid ethyl ester; Nipagin A; Solbrol A; Tegosept E; Uniphen P- 23. 3 Chemical Name and CAS Registry Number Ethyl-4-hydroxybenzoate [120-47-8] 4 Empirical Formula and Molecular Weight C9H10O3 166.18 5 Structural Formula SEM 2: Excipient: ethylparaben; magnification: 3000Â. 6 Functional Category Antimicrobial preservative. 7 Applications in Pharmaceutical Formulation or Technology Ethylparaben is widely used as an antimicrobial preservative in cosmetics,(1) food products, and pharmaceutical formulations. It may be used either alone or in combination with other paraben esters or with other antimicrobial agents. In cosmetics it is one of the most frequently used preservatives. The parabens are effective over a wide pH range and have a broad spectrum of antimicrobial activity, although they are most effective against yeasts and molds; see Section 10. Owing to the poor solubility of the parabens, paraben salts, particularly the sodium salt, are frequently used. However, this may cause the pH of poorly buffered formulations to become more alkaline. See Methylparaben for further information. 8 Description Ethylparaben occurs as a white, odorless or almost odorless, active against yeasts and molds than against bacteria. They crystalline powder. are also more active against Gram-positive than against Gram-negative bacteria. 9 Pharmacopeial Specifications The activity of the parabens increases with increasing chain See Table I. See also Section 18. length of the alkyl moiety, but solubility decreases.
    [Show full text]
  • Quaternary Ammonium Compounds
    FACT SHEET: Quaternary Ammonium Compounds Quaternary ammonium compounds, also known as “quats” or “QACs,” include a number of chemicals used as sanitizers and disinfectants, including benzalkonium chloride, benzethonium chloride, cetalkonium chloride, cetrimide, cetrimonium bromide, cetylpyridinium chloride, glycidyl trimethyl, ammonium chloride, and stearalkonium chloride.[i] In general, quats cause toxic effects through all Mutagenicity routes of exposure including inhalation, Some quats have shown to be mutagenic and to ingestion, dermal application, and irrigation of damage animal DNA and DNA in human body cavities. Exposure to diluted solutions may lymphocytes at much lower levels than are result in mild irritation, while concentrated present in cleaning chemicals.[6] solutions are corrosive, causing burns to the skin and mucous Membranes. They can produce Antimicrobial Resistance systemic toxicity and can also cause allergic Genes have been discovered that mediate reactions.[2] resistance to quats. There has been an association of some of these genes with beta lactamase genes, Asthma and Allergies raising concern for a relationship between Of particular interest with regard to use as disinfectant resistance and antibiotic resistance.[7] disinfectants in the COVID-19 pandemic, quats increase the risk for asthma and allergic Reproductive Toxicity sensitization. Evidence from occupational Mice whose cages were cleaned with QACs had exposures shows increased risk of rhinitis and very low fertility rates. [8] Exposure to a common asthma
    [Show full text]
  • PRICELIST-1920-FINAL.Pdf
    INDEX Page No. MD Speech 01 Our Vision / Our Mission 02 Product Classification and Grade Information 03 Label Information 04 GHS Compliance 05 Technical Data Sheet and COA 06 Qualikems Product Range 07 ISO Certificate 08 - 09 Company Details 10 Ordering Information 11 Terms & Conditions 12 Rate List 13 - 52 Images of Lab / Plant / R & D 53 - 58 Rate List 59 -116 BELIEVING yourselfIN IS THE FIRST SECRET TO Success Dear Reader, The document you are holding is the result of work performed by the team of professionals of QUALIKEMS. It is the fruit of our teams extensive technical experience combine with the collaboration of our customers, who have offered us their valuable comments and proposals for improvement. At Qualikems, we have been working and investing for many years with our thoughts focused on the long term. Only thus can this comprehensive catalogue be kept up to date with the products you need. Our highly trained workforce, using state of the art technology, is the driving force behind the management of our modern factory, and our principal aim is to guarantee that the QUALIKEMS product range meets the conditions you require. QUALIKEMS reinforces industrial character and the path to progress we have continuously forged over the years. This path requires the responsible use of resources and the sustainability of our business activity. It is likewise requires and ability to keep on growing as the way to earn and to preserve our status as the leading supplier of laboratory reagents to our Clients Ashok Sahni Managing Director QUALIKEMS FINE CHEM PVT.
    [Show full text]
  • 162 Part 175—Indirect Food Addi
    § 174.6 21 CFR Ch. I (4–1–19 Edition) (c) The existence in this subchapter B Subpart B—Substances for Use Only as of a regulation prescribing safe condi- Components of Adhesives tions for the use of a substance as an Sec. article or component of articles that 175.105 Adhesives. contact food shall not be construed as 175.125 Pressure-sensitive adhesives. implying that such substance may be safely used as a direct additive in food. Subpart C—Substances for Use as (d) Substances that under conditions Components of Coatings of good manufacturing practice may be 175.210 Acrylate ester copolymer coating. safely used as components of articles 175.230 Hot-melt strippable food coatings. that contact food include the fol- 175.250 Paraffin (synthetic). lowing, subject to any prescribed limi- 175.260 Partial phosphoric acid esters of pol- yester resins. tations: 175.270 Poly(vinyl fluoride) resins. (1) Substances generally recognized 175.300 Resinous and polymeric coatings. as safe in or on food. 175.320 Resinous and polymeric coatings for (2) Substances generally recognized polyolefin films. as safe for their intended use in food 175.350 Vinyl acetate/crotonic acid copoly- mer. packaging. 175.360 Vinylidene chloride copolymer coat- (3) Substances used in accordance ings for nylon film. with a prior sanction or approval. 175.365 Vinylidene chloride copolymer coat- (4) Substances permitted for use by ings for polycarbonate film. 175.380 Xylene-formaldehyde resins con- regulations in this part and parts 175, densed with 4,4′-isopropylidenediphenol- 176, 177, 178 and § 179.45 of this chapter.
    [Show full text]
  • FDA-2015-N-0101; and FDA-2016-N-0124
    DE PARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 November 18, 2020 Docket Nos. FDA-1975-N-0012; FDA-2015-N-0101; and FDA-2016-N-0124 The American Cleaning Institute Attention: James Kim, PhD Vice President, Science and Regulatory Affairs 1401 H Street, N.W. Suite 700 Washington, D.C. 20005 Re: Benzalkonium Chloride, Benzethonium Chloride, Chloroxylenol, Ethanol, and Povidone-Iodine Dear Dr. Kim: This letter responds to The American Cleaning Institute’s (ACI’s) July 14, 2020 communication regarding the deferral from final rulemaking under the over-the-counter (OTC) Drug Review on benzalkonium chloride, benzethonium chloride, chloroxylenol, ethanol, and povidone-iodine for use in nonprescription (often referred to as over-the-counter or OTC) consumer antiseptic wash, health care antiseptic, and consumer antiseptic rub drug products. In March 2016, FDA issued letters granting requests to defer three active ingredients— benzalkonium chloride, benzethonium chloride, and chloroxylenol—from inclusion in the final rulemaking for the December 2013 proposed rule for OTC consumer antiseptic washes (78 FR 76444). Similarly, in January 2017, FDA issued letters granting requests to defer six active ingredients—benzalkonium chloride, benzethonium chloride, chloroxylenol, ethanol, povidone- iodine, and isopropyl alcohol—from inclusion in the final rulemaking for the May 2015 proposed rule for OTC health care antiseptics (80 FR 25166). In October 2017, FDA issued letters granting requests to defer three active
    [Show full text]
  • Environmental Protection Agency § 117.3
    Environmental Protection Agency § 117.3 (iii) Which are used or could be used (j) Process waste water means any for industrial purposes by industries in water which, during manufacturing or interstate commerce; processing, comes into direct contact (4) All impoundments of waters oth- with or results from the production or erwise defined as navigable waters use of any raw material, intermediate under this paragraph; product, finished product, byproduct, (5) Tributaries of waters identified in or waste product. paragraphs (i) (1) through (4) of this section, including adjacent wetlands; [44 FR 50776, Aug. 29, 1979, as amended at 58 and FR 45039, Aug. 25, 1993; 65 FR 30904, May 15, (6) Wetlands adjacent to waters iden- 2000] tified in paragraphs (i) (1) through (5) of this section (‘‘Wetlands’’ means § 117.2 Abbreviations. those areas that are inundated or satu- NPDES equals National Pollutant rated by surface or ground water at a Discharge Elimination System. RQ frequency and duration sufficient to equals reportable quantity. support, and that under normal cir- cumstances do support, a prevalence of § 117.3 Determination of reportable vegetation typically adapted for life in quantities. saturated soil conditions. Wetlands Each substance in Table 117.3 that is generally included playa lakes, listed in Table 302.4, 40 CFR part 302, is swamps, marshes, bogs, and similar assigned the reportable quantity listed areas such as sloughs, prairie potholes, in Table 302.4 for that substance. wet meadows, prairie river overflows, mudflats, and natural ponds): Provided, TABLE 117.3—REPORTABLE QUANTITIES That waste treatment systems (other OF HAZARDOUS SUBSTANCES DES- than cooling ponds meeting the cri- IGNATED PURSUANT TO SECTION 311 OF teria of this paragraph) are not waters THE CLEAN WATER ACT of the United States.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Genetic Basis of Resistance to Quaternary Ammonium Compounds – the Qac Genes and Their Role: a Review
    Veterinarni Medicina, 57, 2012 (6): 275–281 Review Article Genetic basis of resistance to quaternary ammonium compounds – the qac genes and their role: a review Z. Jaglic, D. Cervinkova Veterinary Research Institute, Brno, Czech Republic ABSTRACT: Although the qac genes are named after one of their main substrates (i.e., quaternary ammonium compounds), these genes also code for resistance to a broad spectrum of other cationic compounds such as inter- calating dyes, diamidines and biguanides. The various Qac proteins are involved in relatively low specific efflux- based multidrug pumps and belong to a family of small multidrug resistance proteins. Even though the practical significance of qac-mediated resistance lies mainly in resistance to antiseptics, contradictory findings on this issue are still reported. Therefore, the aim of this review is to summarise the current knowledge on qac-mediated resistance with special emphasis on resistance to antiseptics and its relevance for practice. Keywords: antimicrobial; disinfectant; biocide; benzalkonium; chlorhexidine; cation; susceptibility Contents 3.2. Substrates of qac-mediated resistance 1. Introduction 3.3. Adaptive response to antiseptics 2. The qac genes and their distribution 4. The qac genes and resistance to antibiotics 3. Qac-mediated resistance 5. Conclusions 3.1. Mechanisms of qac-mediated resistance 6. References 1. Introduction first described genetic determinant of resistance to antiseptics was the qacA gene found on pSK1 Resistance to intercalating dyes (i.e. acriflavine and β-lactamase/heavy metal resistance plasmids and ethidium) was associated with particular ge- (Gillespie et al. 1986; Lyon and Skurray 1987). A netic elements, namely staphylococcal β-lactamase range of other qac genes linked with particular plas- plasmids, already more than 40 years ago (Ericson mids (Littlejohn et al.
    [Show full text]